Transforming the Funding of Life Sciences Through Collaborative Capital
APPROVED PRODUCT ROYALTY MONETIZATION
The biopharmaceutical industry is undergoing a period of strong growth and unprecedented innovation. We intend to further this innovation by acquiring royalties on leading biopharmaceutical products.
lnk Royalty Monetization
We seek to acquire royalties on innovative product candidates in the late-stages of clinical development. We collaborate directly with innovators to acquire a new synthetic royalty, monetize an existing royalty or provide capital to an innovator to co-fund clinical development of a product candidate in exchange for a royalty.